William Hait Johnson & Johnson (JNJ) insider trading activity

JNJ Quotes by TradingView

William Hait is EVP, Chief EI and Med Officer of JOHNSON & JOHNSON. Currently has a direct ownership of 38,647 shares of JNJ, which is worth approximately $6.36 Million. The most recent transaction as insider was on Feb 13, 2024, when has been sold 427 shares (Common Stock) at a price of $157.85 per share, resulting in proceeds of $67,401. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 38.6K
0% 3M change
55.6% 12M change
Total Value Held $6.36 Million

William Hait Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 13 2024
SELL
Payment of exercise price or tax liability
$67,401 $157.85 p/Share
427 Reduced 1.09%
38,647 Common Stock
Feb 13 2024
BUY
Exercise of conversion of derivative security
-
834 Added 2.09%
39,074 Common Stock
Feb 12 2024
SELL
Payment of exercise price or tax liability
$641,562 $157.4 p/Share
4,076 Reduced 9.63%
38,240 Common Stock
Feb 12 2024
BUY
Exercise of conversion of derivative security
-
8,932 Added 17.43%
42,316 Common Stock
Feb 08 2024
SELL
Payment of exercise price or tax liability
$173,995 $156.33 p/Share
1,113 Reduced 3.23%
33,384 Common Stock
Feb 08 2024
BUY
Exercise of conversion of derivative security
-
3,059 Added 8.15%
34,497 Common Stock
Aug 23 2023
SELL
Sale (or disposition) back to the issuer
-
696 Reduced 0.79%
87,051 Common Stock
Jul 26 2023
SELL
Open market or private sale
$2,528,056 $172.0 p/Share
14,698 Reduced 14.35%
87,747 Common Stock
Jul 26 2023
BUY
Exercise of conversion of derivative security
$1,329,287 $90.44 p/Share
14,698 Added 12.55%
102,445 Common Stock
Feb 13 2023
SELL
Payment of exercise price or tax liability
$742,977 $162.01 p/Share
4,586 Reduced 4.97%
87,747 Common Stock
Feb 13 2023
BUY
Grant, award, or other acquisition
-
9,640 Added 9.45%
92,333 Common Stock
Feb 10 2023
SELL
Payment of exercise price or tax liability
$226,749 $162.08 p/Share
1,399 Reduced 1.66%
82,693 Common Stock
Feb 10 2023
BUY
Exercise of conversion of derivative security
-
3,856 Added 4.38%
84,092 Common Stock
Oct 24 2022
SELL
Open market or private sale
$2,573,250 $171.55 p/Share
15,000 Reduced 15.75%
80,236 Common Stock
Oct 24 2022
BUY
Exercise of conversion of derivative security
$1,356,600 $90.44 p/Share
15,000 Added 13.61%
95,236 Common Stock
Apr 21 2022
SELL
Open market or private sale
$5,452,142 $183.58 p/Share
29,699 Reduced 27.02%
80,236 Common Stock
Apr 21 2022
BUY
Exercise of conversion of derivative security
$2,685,978 $90.44 p/Share
29,699 Added 21.27%
109,935 Common Stock
Feb 15 2022
SELL
Payment of exercise price or tax liability
$689,771 $165.89 p/Share
4,158 Reduced 4.93%
80,236 Common Stock
Feb 15 2022
BUY
Exercise of conversion of derivative security
-
8,128 Added 8.78%
84,394 Common Stock
Feb 14 2022
SELL
Payment of exercise price or tax liability
$529,007 $168.85 p/Share
3,133 Reduced 1.36%
227,815 Common Stock
Feb 14 2022
BUY
Exercise of conversion of derivative security
-
7,790 Added 3.26%
230,948 Common Stock
WH

William Hait

EVP, Chief EI and Med Officer
New Brunswick, NJ

Track Institutional and Insider Activities on JNJ

Follow JOHNSON & JOHNSON and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JNJ shares.

Notify only if

Insider Trading

Get notified when an Johnson & Johnson insider buys or sells JNJ shares.

Notify only if

News

Receive news related to JOHNSON & JOHNSON

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on JNJ